Background: CD8 stem-cell like memory T cells (TSCM cells) have been recently identified in humans, mice and non-human primates, and seem to represent the most immature memory CD8 T cell population with potent abilities to proliferate and repopulate the memory T cell pool. The presence and the function of CD8 TSCM cells in HIV-1 positive individuals are unknown.
Methods: CD8 TSCM cells were analyzed in 61 HIV-1-positive patients (31 with HAART-suppressed HIV-1 infection, 14 with untreated progressive HIV-1 infection, and 16 untreated HIV-1 controllers (viremia < 1000 RNA copies/ml). Phenotype and function of CD8 TSCM cells were assessed by flow cytometry; virus-specific CD8 T cell populations (n=90 HIV-1-specific responses, n=24 CMV/EBV/Flu-specific responses) were identified by MHC class I multimer staining or intracellular cytokine staining. 12 HIV-1 negative study subjects were analyzed as controls.
Results: Levels of TSCM in total CD8 T cells were significantly decreased in untreated HIV-1-infected patients (p<0.007), but not different between HAART-treated HIV-1 patients and HIIV-1-negative subjects. Among all HIV-1 patients, total and HIV-1-specific CD8 TSCM cells were most frequent in HAART-treated patients (p<0.0001). CD8 TSCM cell frequency was directly associated with years of treatment (p<0.0001, r=0.66) and inversely associated with immune activation (p=0.007, r=-0.3) and apoptosis (p=0.03, r=-0.27) levels. Moreover, HIV-1-specific CD8 TSCM cells from HAART-treated patients showed the highest degree of polyfunctionality in comparison to the other groups of patients (p<0.005). Conclusions: Polyfunctional HIV-1-specific CD8 TSCM cells are able to persist long-term and show a relative accumulation during antiretroviral therapy when viral antigen is pharmacologically suppressed. Due to their apparent antigen-independent persistence in HAART-treated patients, these cells may play an important role in targeting the reservoir of HIV-1-infected cells after pharmacological reversion of viral latency.